TELA Bio (TELA) Director Joseph Capper Buys 75,000 Shares

What Happened Joseph H. Capper, a director of TELA Bio, reported two purchases (Form 4 code P) totaling 75,000 shares. On 2026-09-16 he acquired 50,000 shares at a reported weighted-average price of $1.17 (total $58,265). On 2026-09-17 he acquired 25,000 shares at a reported weighted-average price of $1.22 (total $30,530). Combined, the transactions cost $88,795. These were purchases (buying shares), which are typically viewed as more informative than routine sales.

Key Details

• Transaction dates and reported prices:
  • 2026-09-16: 50,000 shares at $1.17 (weighted avg; see footnote F1)
  • 2026-09-17: 25,000 shares at $1.22 (weighted avg; see footnote F2)
• Reported totals: $58,265 (Sep 16) and $30,530 (Sep 17); aggregate $88,795.
• Footnotes: F1/F2 note the reported prices are weighted averages from multiple trades. Ranges provided — Sep 16 trades ranged $1.14–$1.20; Sep 17 trades ranged $1.19–$1.25. The filer will provide a breakdown of per-trade prices on request.
• Shares owned after the transactions: Not specified in the provided excerpt — check the full Form 4 for post-transaction holdings.
• Filing timeliness: Reported on 2026-09-18 for transactions on 2026-09-16–17; appears to be timely under Form 4 rules.

Context These were open-market or private purchases (Form 4 code P). Purchases by company insiders can signal confidence but are not proof of future performance; stay factual and consult the full filing for exact holdings and any further disclosures.